Login

Dror Bashan, CEO, Protalix Biotherapeutics Inc 00:00:00

Share On Facebook Share On Twitter

Protalix BioTherapeutics looks to commercialize its Fabry Disease therapy

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
Interview with Anthony Jabbour, CEO Black Knight | Anythony Jabbour, CEO, Black Knight IncBKI:NYQ
00:10:00
September 17 Quarterly Economic Update: Insights from Justin Hyland and Will Hickson | Justin Hyland, Managing Director, Hyland Financial Planning.
00:10:00
Joining the ESG Data Convergence Initiative: Insights and Impact
00:10:00
Navigating the Real Estate Landscape: Insights from a Tech CEO| Robert Reffkin, CEO, Compass Inc.
00:10:00
Unlocking Anticipatory CX: Strategies for Enhanced Customer Engagement | Dudley Slater , Chairman at Fusion Connect Inc
00:10:00
"Investing 101: Brendan Caldwell's Guide for Millennials and Gen Z"
00:10:00
Venture Access Alliance Member Spotlight|Ashley Aydin,Principal,Vamos Ventures
00:10:00
Dr. Nathan Gillett on Climate Modeling and Canada's Fight Against Climate Change
00:10:00
Global biotechnology company with a dedicated mission to be at the heart of cancer care|Dr Daniel Tillett,Chief Executive Officer,Race Oncology Ltd
00:10:00
Benoist Grossmann Discusses France's Thriving Venture Capital Market | Benoist Grossmann, Managing Partner, Idinvest Partners.
00:10:00
The Impact of Misleading Headlines: David John Marotta on the Misinterpretation of Financial Advice | David John Marotta, President , Marotta Wealth Management Inc.
00:10:00
5 Key Cybersecurity Strategies for Business Preparedness in 2021

© 2017 - Neuhu+